Century Business Media Ltd vs Sheel Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Century Business Media Ltd is ₹ 56 as of 22 Oct 15:30 . The P/E Ratio of Century Business Media Ltd is 0 as of March 2023 .The P/E Ratio of Sheel Biotech Ltd is 0 as of March 2023 . The Market Cap of Century Business Media Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Sheel Biotech Ltd is ₹ 0 crore as of March 2023 . The Dividend Payout of Century Business Media Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 0 % on March 2026 . This represents a CAGR of -100.00% over 5 years .

About Century Business Media Ltd

Century Business Media Limited was originally incorporated as a private Company as 'Century Business Private Limited' on September 23, 1999 with the Registrar of Companies, Bihar.
Company changed the name to 'Century Business Media Private Limited' vide a fresh Certificate of Incorporation dated February 08, 2024 issued by the Registrar of Companies, Patna.
Further, it converted the status into a Public Company and the name of Company has been changed to 'Century Business Media Limited' dated September 16, 2024 issued by the Registrar of Companies, Central Registration Centre. Company offers Out-of-Home (OOH) advertising solutions across digital and non-digital formats, primarily in Airport (AOOH) and Railway (ROOH) segments, and recently in Metro (MOOH) advertising on Platform Screen Doors.

About Sheel Biotech Ltd

Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992. The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.

FAQs for the comparison of null and Sheel Biotech Ltd

Which company has a larger market capitalization, Century Business Media Ltd or Sheel Biotech Ltd?

Market cap of Century Business Media Ltd is 49 Cr while Market cap of Sheel Biotech Ltd is 119 Cr

What are the key factors driving the stock performance of Century Business Media Ltd and Sheel Biotech Ltd?

The stock performance of Century Business Media Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Century Business Media Ltd and Sheel Biotech Ltd?

As of October 25, 2026, the Century Business Media Ltd stock price is INR ₹56.0. On the other hand, Sheel Biotech Ltd stock price is INR ₹58.95.

How do dividend payouts of Century Business Media Ltd and Sheel Biotech Ltd compare?

To compare the dividend payouts of Century Business Media Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.